AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2018
Jan 22, 2018
31708_dirs_2018-01-22_6e64c3e6-0310-482f-9ec3-2fc05d5af019.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2018-01-18
Reporting Person: Kamke Trent G (Senior V. P., Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-18 | Common Stock | M | 16328 | $6.23 | Acquired | 32682 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-18 | Stock Option (Right to Buy) | $6.23 | M | 16328 | Disposed | 2019-07-25 | Common Stock (16328) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: This option is fully vested and exercisable.
More from LEMAITRE VASCULAR INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Board/Management Information
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3